Directly targeting p70S6K1 also reduces proliferation and invasion in ovarian cancer cells, though there is no rescue of expression of the CDK-inhibitor p27KIP1 that is seen in targeting p100-α or AKT1 [35]. Here, AKT1 is linked to ovarian cancer.